123 related articles for article (PubMed ID: 31051182)
1. Phosphodiesterase type 3A (PDE3A), but not type 3B (PDE3B), contributes to the adverse cardiac remodeling induced by pressure overload.
Polidovitch N; Yang S; Sun H; Lakin R; Ahmad F; Gao X; Turnbull PC; Chiarello C; Perry CGR; Manganiello V; Yang P; Backx PH
J Mol Cell Cardiol; 2019 Jul; 132():60-70. PubMed ID: 31051182
[TBL] [Abstract][Full Text] [Related]
2. Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice.
Sun B; Li H; Shakur Y; Hensley J; Hockman S; Kambayashi J; Manganiello VC; Liu Y
Cell Signal; 2007 Aug; 19(8):1765-71. PubMed ID: 17482796
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart.
Beca S; Ahmad F; Shen W; Liu J; Makary S; Polidovitch N; Sun J; Hockman S; Chung YW; Movsesian M; Murphy E; Manganiello V; Backx PH
Circ Res; 2013 Jan; 112(2):289-97. PubMed ID: 23168336
[TBL] [Abstract][Full Text] [Related]
4. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.
Ding B; Abe JI; Wei H; Huang Q; Walsh RA; Molina CA; Zhao A; Sadoshima J; Blaxall BC; Berk BC; Yan C
Circulation; 2005 May; 111(19):2469-2476. PubMed ID: 15867171
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
Liu H; Maurice DH
Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.
Chung YW; Lagranha C; Chen Y; Sun J; Tong G; Hockman SC; Ahmad F; Esfahani SG; Bae DH; Polidovitch N; Wu J; Rhee DK; Lee BS; Gucek M; Daniels MP; Brantner CA; Backx PH; Murphy E; Manganiello VC
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2253-62. PubMed ID: 25877153
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury.
Oikawa M; Wu M; Lim S; Knight WE; Miller CL; Cai Y; Lu Y; Blaxall BC; Takeishi Y; Abe J; Yan C
J Mol Cell Cardiol; 2013 Nov; 64():11-9. PubMed ID: 23988739
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase.
Dünnes S; Voussen B; Aue A; Groneberg K; Nikolaev V; Groneberg D; Friebe A
Pflugers Arch; 2018 Apr; 470(4):693-702. PubMed ID: 29294149
[TBL] [Abstract][Full Text] [Related]
9. Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.
Ahmad F; Shen W; Vandeput F; Szabo-Fresnais N; Krall J; Degerman E; Goetz F; Klussmann E; Movsesian M; Manganiello V
J Biol Chem; 2015 Mar; 290(11):6763-76. PubMed ID: 25593322
[TBL] [Abstract][Full Text] [Related]
10. Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
Ercu M; Mücke MB; Pallien T; Markó L; Sholokh A; Schächterle C; Aydin A; Kidd A; Walter S; Esmati Y; McMurray BJ; Lato DF; Yumi Sunaga-Franze D; Dierks PH; Flores BIM; Walker-Gray R; Gong M; Merticariu C; Zühlke K; Russwurm M; Liu T; Batolomaeus TUP; Pautz S; Schelenz S; Taube M; Napieczynska H; Heuser A; Eichhorst J; Lehmann M; Miller DC; Diecke S; Qadri F; Popova E; Langanki R; Movsesian MA; Herberg FW; Forslund SK; Müller DN; Borodina T; Maass PG; Bähring S; Hübner N; Bader M; Klussmann E
Circulation; 2022 Dec; 146(23):1758-1778. PubMed ID: 36259389
[TBL] [Abstract][Full Text] [Related]
11. Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues.
Palmer D; Maurice DH
Mol Pharmacol; 2000 Aug; 58(2):247-52. PubMed ID: 10908291
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 3B (PDE3B) antagonizes the anti-angiogenic actions of PKA in human and murine endothelial cells.
MacKeil JL; Brzezinska P; Burke-Kleinman J; Theilmann AL; Nicol CJB; Ormiston ML; Maurice DH
Cell Signal; 2019 Oct; 62():109342. PubMed ID: 31176020
[TBL] [Abstract][Full Text] [Related]
13. A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis.
Ding B; Abe J; Wei H; Xu H; Che W; Aizawa T; Liu W; Molina CA; Sadoshima J; Blaxall BC; Berk BC; Yan C
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14771-6. PubMed ID: 16186489
[TBL] [Abstract][Full Text] [Related]
14. Expression of Recombinant Phosphodiesterases 3A and 3B Using Baculovirus Expression System.
Yan Y; Jiang W; Liu J; Xu W; Qian H
Iran J Biotechnol; 2016 Dec; 14(4):236-242. PubMed ID: 28959341
[TBL] [Abstract][Full Text] [Related]
15. Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.
Netherton SJ; Jimmo SL; Palmer D; Tilley DG; Dunkerley HA; Raymond DR; Russell JC; Absher PM; Sage EH; Vernon RB; Maurice DH
Diabetes; 2002 Apr; 51(4):1194-200. PubMed ID: 11916944
[TBL] [Abstract][Full Text] [Related]
16. Differences in phosphodiesterase 3A and 3B expression after ischemic insult.
Mitome-Mishima Y; Miyamoto N; Tanaka R; Oishi H; Arai H; Hattori N; Urabe T
Neurosci Res; 2013 Apr; 75(4):340-8. PubMed ID: 23471014
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide phosphodiesterase 3 expression in vivo: evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats.
Nagaoka T; Shirakawa T; Balon TW; Russell JC; Fujita-Yamaguchi Y
Diabetes; 1998 Jul; 47(7):1135-44. PubMed ID: 9648839
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide activates AMPK by modulating PDE3A in human pulmonary artery smooth muscle cells.
Dillard J; Meng X; Nelin L; Liu Y; Chen B
Physiol Rep; 2020 Sep; 8(17):e14559. PubMed ID: 32914566
[TBL] [Abstract][Full Text] [Related]
20. cUMP hydrolysis by PDE3A.
Berrisch S; Ostermeyer J; Kaever V; Kälble S; Hilfiker-Kleiner D; Seifert R; Schneider EH
Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):269-280. PubMed ID: 27975297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
